ED

86 days ago

Futura Medical 2025 results really are a limp dick – will it even survive into 2027?

The fundamental problem that Futura Medical (FUM) has always had is that its ED product Eroxxon does not seem to impress users at all and thus repeat orders are minimal and with high marketing costs to win new custom it has always been doomed.  Calendar 20025 results out today are window dressed but appalling. The warnings about when the Fat Lady could be calling are explicit. This has a zero written all over it, as Lucian and I have been warning for years.

169 days ago

Futura Medical doesn’t give you a stiffy but it is screwed

No doubt crazy Meg at Bloomberg will be condemning my crude language and double entendres and saying that it damages AIM and my own credibility while also blaming myself and Lucian (and the global shorting conspiracy) for shares in Futura Medical (FUM) crashing from 52p to 1.3p in just 29 months. It is all down to our beastly and hurty words and nothing to do with the fact that the financials have been atrocious as there are so few repeat purchases of the company’s ED product.

350 days ago

Futura Medical: at least the bears if not the customers get a stiffy, yet another warning

We bears have maintained all along that the problem that Futura Medical (FUM) is that customers do not think that its main product Eroxon, a supposed treatment for ED, is very good. Customer reviews are dire, repeat orders weak and that was always going to sink the ship. Today comes yet another warning.

380 days ago

Tom Winnifrith Bearcast: Matthew's Dog and Catriona will love the smut, is it time to turn bullish on Futura Medical?

I start with laptop issues which have delayed today. Then it is onto Futura Medical (FUM) a great bear call in the world of ED from myself and Lucian Miers. But is now the time to turn bullish? I discuss.

469 days ago

Futura Medical: Trump Tariffs the excuse with the next warning?

Who knows what the Orange man will say or do next? I do not claim to know but it is clear that the tariff war is causing both businesses and consumers to defer or change purchasing patterns. A number of companies with exposure to the US have already withdrawn earnings guidance. For Futura Medical (FUM), producer of Eroxon, an ED product that does not seem to work very well, the US is a key market.

1079 days ago

Futura Medical approval to launch ED gel in Saudi but who cares? Just look at the terrible reviews

Apparently Saudi is one of the world’s top ten markets for Erectile Disfunction products with 10.45% of married Saudi males unable to get it up. And so Futura Medical (FUM) is terribly excited today about getting regulatory approval for Eroxon its gel which, it claims, allows you to get a stiffy within ten minutes. But…